Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71376 - 71400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	LAMC2	3918	upregulated	Silicon Dioxide analog results in increased expression of LAMC2 mRNA	1q25.3	A24195
Silicon dioxide	Approved	LAMC2	3918	upregulated	Silicon Dioxide results in increased expression of LAMC2 mRNA	1q25.3	A24196
Silicon dioxide	Approved	LAMP1	3916	upregulated	Silicon Dioxide analog results in increased expression of LAMP1 mRNA	13q34	A24194
Silicon dioxide	Approved	LANCL1	10314	downregulated	Silicon Dioxide analog results in decreased expression of LANCL1 mRNA	2q34	A24195
Silicon dioxide	Approved	LARGE1	9215	downregulated	Silicon Dioxide analog results in decreased expression of LARGE1 mRNA	22q12.3	A24195
Silicon dioxide	Approved	LARS2	23395	upregulated	Silicon Dioxide results in increased expression of LARS2 mRNA	3p21.31	A24196
Silicon dioxide	Approved	LAT	27040	upregulated	Silicon Dioxide analog results in increased expression of LAT mRNA	16q13	A24195
Silicon dioxide	Approved	LAT2	7462	upregulated	Silicon Dioxide analog results in increased expression of LAT2 mRNA	7q11.23	A24194
Silicon dioxide	Approved	LATS1	9113	upregulated	Silicon Dioxide analog results in increased expression of LATS1 mRNA	6q25.1	A24195
Silicon dioxide	Approved	LAYN	143903	upregulated	Silicon Dioxide analog results in increased expression of LAYN mRNA	11q23.1	A24195
Silicon dioxide	Approved	LBH	81606	downregulated	Silicon Dioxide analog results in decreased expression of LBH mRNA	2p23.1	A24195
Silicon dioxide	Approved	LBH	81606	upregulated	Silicon Dioxide results in increased expression of LBH mRNA	2p23.1	A24196
Silicon dioxide	Approved	LBP	3929	downregulated	Silicon Dioxide analog results in decreased expression of LBP mRNA	20q11.23	A24195
Silicon dioxide	Approved	LCAT	3931	upregulated	Silicon Dioxide results in increased expression of LCAT mRNA	16q22.1	A24196
Silicon dioxide	Approved	LCE1A	353131	upregulated	Silicon Dioxide analog results in increased expression of LCE1A mRNA	1q21.3	A24195
Silicon dioxide	Approved	LCE3D	84648	upregulated	Silicon Dioxide analog results in increased expression of LCE3D mRNA	1q21.3	A24195
Silicon dioxide	Approved	LCMT2	9836	downregulated	Silicon Dioxide results in decreased expression of LCMT2 mRNA	15q15.3	A24196
Silicon dioxide	Approved	LCN2	3934	downregulated	Silicon Dioxide analog results in decreased expression of LCN2 mRNA	9q34.11	A24195
Silicon dioxide	Approved	LCP1	3936	upregulated	Silicon Dioxide analog results in increased expression of LCP1 mRNA	13q14.13	A24195
Silicon dioxide	Approved	LCP2	3937	upregulated	Silicon Dioxide analog results in increased expression of LCP2 mRNA	5q35.1	A24194
Silicon dioxide	Approved	LDHA	3939	downregulated	Silicon Dioxide analog results in decreased expression of LDHA mRNA	11p15.1	A24194
Silicon dioxide	Approved	LDHD	197257	downregulated	Silicon Dioxide analog results in decreased expression of LDHD mRNA	16q23.1	A24195
Silicon dioxide	Approved	LDLR	3949	upregulated	Silicon Dioxide results in increased expression of LDLR mRNA	19p13.2	A24196
Silicon dioxide	Approved	LDLRAD1	388633	downregulated	Silicon Dioxide analog results in decreased expression of LDLRAD1 mRNA	1p32.3	A24195
Silicon dioxide	Approved	LDLRAD3	143458	upregulated	Silicon Dioxide analog results in increased expression of LDLRAD3 mRNA	11p13	A24195

Displaying entries 71376 - 71400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability